<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29145</article-id><article-id pub-id-type="doi">10.7554/eLife.29145</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>A chemical screen in zebrafish embryonic cells establishes that Akt activation is required for neural crest development</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-81003"><name><surname>Ciarlo</surname><given-names>Christie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2876-2432</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82751"><name><surname>Kaufman</surname><given-names>Charles K</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82757"><name><surname>Kinikoglu</surname><given-names>Beste</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82758"><name><surname>Michael</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89732"><name><surname>Yang</surname><given-names>Song</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94700"><name><surname>D′Amato</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82754"><name><surname>Blokzijl-Franke</surname><given-names>Sasja</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82755"><name><surname>den Hertog</surname><given-names>Jeroen</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82752"><name><surname>Schlaeger</surname><given-names>Thorsten M</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82753"><name><surname>Zhou</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89731"><name><surname>Liao</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3910"><name><surname>Zon</surname><given-names>Leonard I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0860-926X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Stem Cell Program and Hematology/Oncology</institution>, <institution>Boston Children's Hospital</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Medicine</institution>, <institution>Washington University School of Medicine</institution>, <addr-line><named-content content-type="city">St. Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Stem Cell Program and Hematology/Oncology</institution>, <institution>Boston Children's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Hubrecht Institute</institution>, <institution>Koninklijke Nederlandse Akademie van Wetenschappen (KNAW), University Medical Center Utrecht</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1203"><name><surname>Whitfield</surname><given-names>Tanya T</given-names></name><role>Reviewing editor</role><aff><institution>University of Sheffield</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zon@enders.tch.harvard.edu</email> (LZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>08</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e29145</elocation-id><history><date date-type="received"><day>31</day><month>05</month><year>2017</year></date><date date-type="accepted"><day>08</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Ciarlo et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Ciarlo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29145-v1.pdf"/><abstract><p>The neural crest is a dynamic progenitor cell population that arises at the border of neural and non-neural ectoderm. The inductive roles of FGF, Wnt, and BMP at the neural plate border are well established, but the signals required for subsequent neural crest development remain poorly characterized. Here, we conducted a screen in primary zebrafish embryo cultures for chemicals that disrupt neural crest development, as read out by <italic>crestin:EGFP </italic>expression. We found that the natural product caffeic acid phenethyl ester (CAPE) disrupts neural crest gene expression, migration, and melanocytic differentiation by reducing Sox10 activity. CAPE inhibits FGF-stimulated PI3K/Akt signaling, and neural crest defects in CAPE-treated embryos are suppressed by constitutively active Akt1. Inhibition of Akt activity by constitutively active PTEN similarly decreases <italic>crestin</italic> expression and Sox10 activity. Our study has identified Akt as a novel intracellular pathway required for neural crest differentiation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F31CA180313</award-id><principal-award-recipient><name><surname>Ciarlo</surname><given-names>Christie</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005190</institution-id><institution>Melanoma Research Alliance</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009160</institution-id><institution>Lawrence Ellison Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01CA103846</award-id><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RO3DE024490</award-id><principal-award-recipient><name><surname>Liao</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>K08AR061071</award-id><principal-award-recipient><name><surname>Kaufman</surname><given-names>Charles K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Leonard I Zon, L.I.Z. is a founder and stock holder of Fate Therapeutics, Marauder Therapeutics, and Scholar Rock..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish were maintained under standard protocols approved by the Boston Children's Hospital (BCH) Institutional Animal Care and Use Committee (IACUC) (protocol # 14-10-2789R).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=kjwrwikmlneppof&amp;acc=GSE95815" source-id-type="uri"><collab>Ciarlo C</collab>, <collab>Kaufman CK</collab>, <collab>Kinikoglu B</collab>, <collab>Michael J</collab>, <collab>Yang S</collab>, <collab>D'Amato C</collab>, <collab>Blokzijl-Franke S</collab>, <collab>den Hertog J</collab>, <collab>Schlaeger TM</collab>, <collab>Zhou Y</collab>, <collab>Liao EC</collab>, <collab>Zon LI</collab>, <year>2017</year><x>,</x> <source>A chemical screen in zebrafish embryonic cells establishes that Akt activation is required for neural crest development</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=kjwrwikmlneppof&amp;acc=GSE95815">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=kjwrwikmlneppof&amp;acc=GSE95815</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE95815)</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataro2" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75356" source-id-type="uri"><collab>Kaufman CK</collab>, <collab>Mosimann C</collab>, <collab>Fan ZP</collab>, <collab>Yang S et al.</collab>, <year>2016</year><x>,</x> <source>A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75356">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75356</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE75356)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-29145-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>